Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1990-11-2
|
pubmed:abstractText |
As an approach toward understanding the mechanisms by which cadmium (Cd) exerts its teratogenic effects, the expression and metal regulation of the metallothionein (MT) genes in midgestation mouse embryos were studied by Northern blot and in situ hybridization. Maternal injection of a teratogenic dosage of Cd (50 mumol Cd/kg body wt) did not induce MT mRNA in day 10 (D10) CD-1 mouse embryos, whereas zinc (Zn) (50 mumol/kg was an effective inducer. In contrast, Cd was about 10-fold more potent than Zn at rapidly inducing MT mRNA in D10 embryos incubated in vitro in medium containing micromolar concentrations of these metals. This suggests that following maternal injection, Cd but not Zn is prevented from reaching the D10 embryo and establishes that the embryonic MT genes are not refractory to metal induction, which might have explained the sensitivity of the embryo to Cd. MT mRNA was detected at high levels only in the extraembryonic membranes of D9 embryos exposed to Cd in vivo. On days 9 and 10, no embryonic cell types contained detectable levels of MT mRNA. This mRNA was detected first at low levels in hepatocytes on D11, soon after formation of liver and these levels increased dramatically by D12. Therefore, Cd teratogenicity was not associated with high levels of cell type-specific expression of the MT genes in Cd-sensitive regions of the embryo (neural tube, limb bud), that might have served to target Cd to these cells. Taken together, the results of this study suggest that Cd teratogenicity reflects damage to maternal or extraembryonic tissues. However, the results cannot exclude the possibility that certain cells in the embryo are exceptionally sensitive to low levels of Cd.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0300-483X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-104
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2219135-Abnormalities, Drug-Induced,
pubmed-meshheading:2219135-Animals,
pubmed-meshheading:2219135-Blotting, Northern,
pubmed-meshheading:2219135-Cadmium,
pubmed-meshheading:2219135-Dose-Response Relationship, Drug,
pubmed-meshheading:2219135-Embryo, Mammalian,
pubmed-meshheading:2219135-Female,
pubmed-meshheading:2219135-Gene Expression,
pubmed-meshheading:2219135-Metallothionein,
pubmed-meshheading:2219135-Mice,
pubmed-meshheading:2219135-Nucleic Acid Hybridization,
pubmed-meshheading:2219135-Pregnancy,
pubmed-meshheading:2219135-RNA, Messenger,
pubmed-meshheading:2219135-RNA Probes
|
pubmed:year |
1990
|
pubmed:articleTitle |
Cadmium teratogenicity and its relationship with metallothionein gene expression in midgestation mouse embryos.
|
pubmed:affiliation |
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City 66103.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|